About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Baltimore | 209 Studies

Clinical Trials Ovarian CancerBaltimore

Ovarian Cancer Clinical Trials in Baltimore

Find 209 clinical trials for ovarian cancer near Baltimore, Maryland. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 209 trials

CompletedClinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian CancerThis research is being done to test the safety of the combination of the study drugs fostamatinib and paclitaxel.NCT03246074·Washington D.C., District of Columbia and 2 others Active not recruitingStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerTo evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the…NCT03937154·Jonesboro, Arkansas and 138 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSecond-Line Treatment for Patients With Platinum-Sensitive Ovarian CancerThe purpose of this study is to compare the progression-free survival of two treatment regimens for relapsed ovarian cancer.NCT00090610·Fort Myers, Florida and 18 others

CompletedPhase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)Patients enrolled into this study will be stratified into 3 groups based on gene mutations identified in their tumor tissue.NCT01968213·Tucson, Arizona and 95 others

Active not recruitingTesting the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy in treating patients with…NCT02446600·Birmingham, Alabama and 355 others

CompletedDovitinib for Patients With Tumor Pathway Activations Inhibited by DovitinibThe purpose of this signal seeking study was to determine whether treatment with dovitinib (TKI258) demonstrated sufficient efficacy in select pathway-activated solid tumors…NCT01831726·Birmingham, Alabama and 48 others

CompletedPhase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003425·Lexington, Kentucky and 3 others

TerminatedStudy of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.Open-label, multi-center, non-randomized, multiple dose, safety, tolerability, pharmacokinetic, and pharmacodynamics and clinical activity study of PF-06940434 (Integrin…NCT04152018·Scottsdale, Arizona and 30 others

RecruitingA Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT06890338·Birmingham, Alabama and 69 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

Active not recruitingP-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsA Phase 1, open label, dose escalation and expanded cohort study of P-MUC1C-ALLO1 in adult subjects with advanced or metastatic epithelial derived solid tumors, including but not…NCT05239143·Irvine, California and 13 others

TerminatedREFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary…NCT05870748·Tucson, Arizona and 62 others

CompletedA Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid TumorsTo determine the maximum tolerated dose or optimal biological dose, and the safety profile of MEDI3617 when given as a single-agent or in combination with other chemotherapeutic…NCT01248949·Los Angeles, California and 9 others

CompletedStudy of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)The purpose of this study is to assess the efficacy and safety of treatment with carboplatin/paclitaxel\* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women…NCT03740165·Birmingham, Alabama and 226 others

CompletedA Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian CancerThe purpose of the research is to determine if blood tests and a CT scan done before surgery can predict how successful the surgery will be.NCT00587093·Baltimore, Maryland and 4 others

CompletedVeliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube CancerThis phase I trial studies the side effects and best dose of veliparib when given together with floxuridine in treating patients with epithelial ovarian, primary peritoneal…NCT01749397·Scottsdale, Arizona and 4 others

CompletedDimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and PaclitaxelRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003569·Chicago, Illinois and 2 others

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 744 others

Active not recruitingHOT: HIPEC in Ovarian Cancer as Initial TreatmentCommunity hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in…NCT02124421·Baltimore, Maryland

Active not recruitingTreatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerThis trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer.NCT03939481·Antioch, California and 168 others

PreviousPage 10 of 11Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia